Alzheimer Biomarkers Higher in Women - Summary - MDSpire

Alzheimer Biomarkers Higher in Women

  • By

  • Kathryn Wighton

  • January 30, 2026

  • 3 min

Share

Objective:

To investigate sex differences in Alzheimer pathology and structural brain resilience in a community-based cohort of adults without cognitive impairment.

Key Findings:
  • Women exhibited higher global amyloid burden than men.
  • Women had greater tau burden in advanced Braak stages compared to men.
  • Women showed greater Alzheimer disease signature cortical thickness and lower white matter hyperintensity burden than men.
  • Sex differences in tau burden were more pronounced among apolipoprotein E epsilon 4 carriers.
Interpretation:

The findings suggest that women may have a unique profile of Alzheimer pathology characterized by higher amyloid and tau levels, alongside structural resilience in certain brain regions.

Limitations:
  • Cross-sectional design limits causal inference.
  • Sex determined by self-report may introduce misclassification.
  • Lack of assessment for gender-related sociocultural factors.
  • Sample unevenly distributed by sex and racial/ethnic subgroups.
Conclusion:

Further research with larger, more balanced cohorts is needed to explore the intersection of sex, race, and ethnicity in Alzheimer disease outcomes.

Original Source(s)

Related Content